# Autoimmunity After Checkpoint Blockade

> **NCT04119713** · — · RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 600 (estimated)

## Conditions studied

- Autoimmunity
- Cancer
- Immunotoxicity
- Oncology

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04119713
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-24
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04119713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04119713, "Autoimmunity After Checkpoint Blockade". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT04119713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*